LIMINAL BIOSCIENCES INC. (LMNL) Financial Statements
LIMINAL BIOSCIENCES INC. (LMNL) files with the U.S. Securities and Exchange Commission under CIK 0001351172. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2022
- Revenue
- 401.00 thousand CAD
- Net Income
- 622.00 thousand CAD
- Total Assets
- 50.46 million CAD
- Net Cash from Operations
- -31.82 million CAD
Fiscal year ended Dec 31, 2022. Latest periodic SEC filing: Mar 15, 2023. Source: SEC filings (EDGAR XBRL). Amounts in CAD.
Open the full financial statements for LMNL in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History